BUGGY JOSEPH J.,MODY TARAK D.,VERNER ERIK J.,PURRO NORBERT,BALASUBRAMANIAN SRIRAM,KLOOS IOANA,DEPIL STÉPHANE,LOURY DAVID J.
申请号：
NZ62122111
公开号：
NZ621221A
申请日:
2011.09.13
申请国别(地区):
NZ
年份:
2016
代理人:
摘要：
Provided are combinations and pharmaceutical compositions comprising bendamustine and a HDAC inhibitor. A preferred HDAC inhibitor is N-hydroxy-4-{ 2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy} -benzamide. The combinations and pharmaceutical compositions are useful in the treatment of cancer.
